- Filed
- May 5, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 2, 2025 | 77.71M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $755.63M |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $34.19M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $27.19M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $239.1M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $246.38M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $918.45M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $922.13M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $2.53B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $2.49B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $1.11B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $1.08B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $4.05B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $4.04B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 77.74M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $15.47M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $15.76M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $1.6B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $1.59B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.04 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.04 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $165.8M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$3.28M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $3.96M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $162.04M |
| Revenue | Q1 2025 · Mar 31, 2024 | $368.87M |